‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

NZ stocks end flat amid Fletcher-SkyCity legal woes
Markets Market Close

NZ stocks end flat amid Fletcher-SkyCity legal woes

Tesla's 14% drop again highlighted the general state of global market uncertainty.

Jamie Gray 06 Jun 2025
SkyCity claims it is entitled to $330m in damages from Fletcher Building
Markets

SkyCity claims it is entitled to $330m in damages from Fletcher Building

The original delivery date of the International Convention Centre was January 2019. 

Rebecca Howard 06 Jun 2025
10 NZ firms could get slice of $200m Fisher KiwiSaver cash
Markets

10 NZ firms could get slice of $200m Fisher KiwiSaver cash

Private equity investing will benefit both KiwiSavers and business, fund manager says.